Extreme variability in succinylcholine dose for muscle relaxation in electroconvulsive therapy
- 5 March 2018
- journal article
- research article
- Published by SAGE Publications in Australasian Psychiatry
- Vol. 26 (4) , 391-393
Abstract
Objectives: To determine what dose of succinylcholine falls outside the range of 2 SD above or below the mean optimal dose of 0.9 mg/kg used for electroconvulsive therapy (ECT). Methods: In this retrospective chart review, for all patients who received ECT at our institution within the 5-year study period, the initial dose of succinylcholine in milligrams per kilogram was compared with subsequent doses after adjustments were made for individual patient responses. Mean and SD were calculated using the dose of succinylcholine, once the optimal dose for each patient had been determined, based on clinical response. Results: Five hundred patients treated during the 5-year period met inclusion criteria, 180 (36%) of whom required an adjustment of the succinylcholine dosing either above (119 patients) or below (61 patients) the 0.9 mg/kg standard after their first treatment. Conclusions: In those patients who required an adjustment of 2 SD either above or below the mean dose of succinylcholine (29 patients, 5.8%), adequate neuromuscular blockade was only achieved with either an increased dose of up to 2.10 mg/kg or a decreased dose as low as 0.29 mg/kg.Keywords
This publication has 18 references indexed in Scilit:
- Response to Succinylcholine in Patients Carrying the K-Variant of the Butyrylcholinesterase GeneAnesthesia & Analgesia, 2013
- Muscle Relaxation in Electroconvulsive TherapyThe Journal of ECT, 2011
- Prolonged Succinylcholine Action During Electroconvulsive Therapy (ECT) After Cytarabine, Vincristine, and Rituximab ChemotherapyThe Journal of ECT, 2011
- Sertraline-induced pseudocholinesterase enzyme deficiencyInternational Journal of General Medicine, 2010
- Pseudocholinesterase enzyme deficiency: a case series and review of the literatureCases Journal, 2009
- Reduced Pseudocholinesterase Activity in Patients With HELLP SyndromeReproductive Sciences, 2007
- Antidepressants inhibit human acetylcholinesterase and butyrylcholinesterase activityBiochimica et Biophysica Acta (BBA) - Molecular Basis of Disease, 2002
- Resistance to Succinylcholine in Myasthenia GravisAnesthesiology, 1988
- Weight, Pseudocholinesterase Activity, and Succinylcholine RequirementAnesthesiology, 1982
- Serum Cholinesterase Activity in Burned Patients I: Biochemical FindingsActa Anaesthesiologica Scandinavica, 1975